Simplex Trading
RCKT icon

Simplex Trading’s Rocket Pharmaceuticals RCKT Stock Holding History

Simplex Trading’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.1K Sell
7,000
-4,900
-41% -$19.5K ﹤0.01% 6575
2025
Q4 		$41.8K Sell
11,900
-8,200
-41% -$28.1K ﹤0.01% 5830
2025
Q3 		$65K Buy
20,100
+700
+4% +$2.21K ﹤0.01% 6190
2025
Q2 		$47K Buy
19,400
+4,100
+27% +$20.8K ﹤0.01% 5992
2025
Q1 		$102K Sell
15,300
-300
-2% -$2.96K ﹤0.01% 5037
2024
Q4 		$196K Buy
15,600
+12,800
+457% +$193K ﹤0.01% 4538
2024
Q3 		$51K Sell
2,800
-700
-20% -$14.3K ﹤0.01% 5865
2024
Q2 		$75K Sell
3,500
-4,400
-56% -$101K ﹤0.01% 5673
2024
Q1 		$212K Sell
7,900
-6,900
-47% -$196K ﹤0.01% 4786
2023
Q4 		$443K Sell
14,800
-33,900
-70% -$748K ﹤0.01% 3825
2023
Q3 		$997K Buy
48,700
+46,800
+2,463% +$851K ﹤0.01% 2658
2023
Q2 		$37K Sell
1,900
-5,900
-76% -$119K ﹤0.01% 6137
2023
Q1 		$133K Buy
7,800
+5,800
+290% +$114K ﹤0.01% 4827
2022
Q4 		$39K Buy
2,000
+1,600
+400% +$29.5K ﹤0.01% 6181
2022
Q3 		$6K Sell
400
-4,500
-92% -$70.2K ﹤0.01% 8670
2022
Q2 		$67K Buy
4,900
+3,800
+345% +$45.3K ﹤0.01% 6103
2022
Q1 		$17K Buy
+1,100
New +$19K ﹤0.01% 8418
2021
Q2 		– Sell
-38
Closed -$168K – 10599
2021
Q1 		$168K Sell
38
-25
-40% -$1.37K ﹤0.01% 5017
2020
Q4 		$345K Buy
+63
New +$2.3K ﹤0.01% 3904
2020
Q2 		– Sell
-37
Closed -$51K – 8219
2020
Q1 		$51K Buy
37
+33
+825% +$653 ﹤0.01% 5112
2019
Q4 		$9K Buy
+4
New +$67 ﹤0.01% 6446
2017
Q4 		– Sell
-20
Closed -$6K – 6549
2017
Q3 		$6K Buy
20
+7
+54% +$32 ﹤0.01% 4261
2017
Q2 		$54K Buy
13
+1
+8% +$7 ﹤0.01% 2327
2017
Q1 		$5K Sell
12
-205
-94% -$1.38K ﹤0.01% 4615
2016
Q4 		$117K Buy
217
+216
+21,600% +$6.16K 0.01% 1409
2016
Q3 		$1K Buy
+1
New +$31 ﹤0.01% 5417

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Simplex Trading's RCKT Position: Q1 2026 in Review

Simplex Trading sold out of Rocket Pharmaceuticals (RCKT) in Q1 2026, closing a stake of 42,495 shares — an estimated $169K sold.

Simplex Trading first reported a position in RCKT in Q2 2016 and held it in 22 quarters. The position peaked at $2.09M in Q3 2023. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Simplex Trading reported no remaining Rocket Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 42,495 Rocket Pharmaceuticals shares in Q1 2026, an estimated $169K.
  • Simplex Trading first reported a position in Rocket Pharmaceuticals in Q2 2016 and held it in 22 quarters.
  • Simplex Trading's Rocket Pharmaceuticals position peaked at $2.09M in Q3 2023.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.